CodeSystem |
http://hl7.org/fhir/us/pq-cmc-fda/CodeSystem/cmc-hierarchy-supplement | PQ-CMC-FDA NCIt Hieararchy Supplement |
http://hl7.org/fhir/us/icsr-ae-reporting/ValueSet/PatientMilitaryStatus | Patient Military Status |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-all-risk-assessment-value-vs | Acute Lymphoblastic Leukemia (ALL) Risk Assessment Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-binet-stage-value-vs | Binet Stage Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-cancer-stage-type-vs | Cancer Stage Type Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-cancer-stage-value-vs | Cancer Stage Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-cancer-staging-method-vs | Cancer Staging Method Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-deauville-scale-vs | Deauville Scale Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-figo-stage-value-vs | FIGO Stage Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-international-retinoblastoma-stage-value-vs | International Retinoblastoma Stage Value |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-lansky-play-performance-vs | Lansky Play Performance Status VS |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-lymphoma-stage-value-vs | Lymphoma Stage Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-lymphoma-staging-method-vs | Lymphoma Staging System Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-myeloma-iss-stage-value-vs | International Staging System (ISS) for Myeloma Stage Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-myeloma-riss-stage-value-vs | Revised International Staging System (ISS) for Multiple Myeloma Stage Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-neuroblastoma-INRGSS-value-vs | International Neuroblastoma Risk Group Staging System (INRGSS) for Neuroblastoma Risk Assessment Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-pretext-stage-value-vs | PRETEXT Stage Value |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-rai-stage-value-vs | Rai Stage Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-rai-staging-method-vs | Rai Staging System Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-rhabdomyosarcoma-assessment-value-vs | Rhabdomyosarcoma Assessment Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-rhabdomyosarcoma-clinical-group-value-vs | Rhabdomyosarcoma Clinical Group Value |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-risk-assessment-type-vs | Risk Assessment Type Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-risk-assessment-vs | Risk Assessment Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-tnm-staging-method-vs | TNM Staging Method Value Set |
http://terminology.hl7.org/ValueSet/adverse-event-clinical-research-causality-relatedness | Adverse Event Clinical Research Causality Relatedness |
http://terminology.hl7.org/ValueSet/adverse-event-clinical-research-grades | Adverse Event Clinical Research Grades |
http://terminology.hl7.org/ValueSet/adverse-event-clinical-research-outcomes | Adverse Event Clinical Research Outcomes |
http://terminology.hl7.org/ValueSet/adverse-event-clinical-research-seriousness-criteria | Adverse Event Clinical Research Seriousness Criteria |
http://hl7.org/fhir/uv/emedicinal-product-info/ValueSet/propertyColor | Color of the product |
http://hl7.org/fhir/uv/emedicinal-product-info/ValueSet/propertyFlavor | Flavor of the product |
http://hl7.org/fhir/uv/emedicinal-product-info/ValueSet/propertyShape | Shape of the product |
http://hl7.org/fhir/uv/phenomics-exchange/ValueSet/DiagnosticMarker | Diagnostic Marker |
http://hl7.org/fhir/uv/phenomics-exchange/ValueSet/HistologicalDiagnosis | HistologicalDiagnosis |
http://hl7.org/fhir/uv/phenomics-exchange/ValueSet/TumorGrade | Tumor Grade |
http://hl7.org/fhir/uv/phenomics-exchange/ValueSet/TumorProgression | Tumor Progression |
http://hl7.org/fhir/uv/phenomics-exchange/ValueSet/TumorStage | Tumor Stage |
http://hl7.org/fhir/uv/phenomics-exchange/ValueSet/phenotypic-abnormality | Phenotypic abnormality ValueSet |
http://hl7.org/fhir/us/codex-radiation-therapy/ValueSet/codexrt-radiotherapy-adverse-event-termVS | Adverse Event Terms Value Set |
http://hl7.org/fhir/us/spl/ValueSet/valueset-businessOperationQualifiers | Business Operation Qualifiers |
http://hl7.org/fhir/us/spl/ValueSet/valueset-establishmentBusinessOperations | Establishment Business Operations |
http://hl7.org/fhir/us/spl/ValueSet/valueset-gdufaFacilityBusinessOperationQualifiers | GDUFA Facility Business Operation Qualifiers |
http://hl7.org/fhir/us/spl/ValueSet/valueset-gdufaFacilityBusinessOperations | GDUFA Facility Business Operations |
http://hl7.org/fhir/us/spl/ValueSet/valueset-labelerBusinessOperations | Labeler Business Operations |
http://hl7.org/fhir/us/spl/ValueSet/valueset-splColor | SPL Color |
http://hl7.org/fhir/us/spl/ValueSet/valueset-splComboProductType | SPL Combo Product Type |
http://hl7.org/fhir/us/spl/ValueSet/valueset-splDoseForm | SPL Dose Form |
http://hl7.org/fhir/us/spl/ValueSet/valueset-splFlavor | SPL Flavor |
http://hl7.org/fhir/us/spl/ValueSet/valueset-splMarketingCategories | SPL Marketing Categories |
http://hl7.org/fhir/us/spl/ValueSet/valueset-splOperationType | SPL Operation Type |
http://hl7.org/fhir/us/spl/ValueSet/valueset-splPackageTypes | SPL Package Types |
http://hl7.org/fhir/us/spl/ValueSet/valueset-splRouteOfAdministration | SPL Route of Administration |
http://hl7.org/fhir/us/spl/ValueSet/valueset-splShape | SPL Shape |
http://hl7.org/fhir/us/spl/ValueSet/valueset-splSpecialMeasures | SPL Special Measures |
http://hl7.org/fhir/us/pq-cmc-fda/ValueSet/capsule-classification-category | Capsule Shell Classification Terminology |
http://hl7.org/fhir/us/pq-cmc-fda/ValueSet/cmc-product-name-types-vs | Product Name Types Terminology |
http://hl7.org/fhir/us/pq-cmc-fda/ValueSet/pqcmc-batch-utilization-terminology | Batch utilization Terminology |
http://hl7.org/fhir/us/pq-cmc-fda/ValueSet/pqcmc-chemical-structure-datafile-type-terminology | Chemical Structure Data File Type Terminology |
http://hl7.org/fhir/us/pq-cmc-fda/ValueSet/pqcmc-closure-type-terminology | Closure Type Terminology |
http://hl7.org/fhir/us/pq-cmc-fda/ValueSet/pqcmc-coating-purpose | Coating Purpose Terminology |
http://hl7.org/fhir/us/pq-cmc-fda/ValueSet/pqcmc-container-type-terminology | Container Type Terminology |
http://hl7.org/fhir/us/pq-cmc-fda/ValueSet/pqcmc-drug-product-component-function-category-terminology | Drug Product Component Function Category Terminology |
http://hl7.org/fhir/us/pq-cmc-fda/ValueSet/pqcmc-excipient-function-terminology | Excipient Function Terminology |
http://hl7.org/fhir/us/pq-cmc-fda/ValueSet/pqcmc-impurity-classification-terminology | Impurity Classification Terminology |
http://hl7.org/fhir/us/pq-cmc-fda/ValueSet/pqcmc-manufactured-dose-form-terminology | Manufactured Dose Form Terminology |
http://hl7.org/fhir/us/pq-cmc-fda/ValueSet/pqcmc-org-identifier-type-terminology | Organization-Site Identifier Terminology |
http://hl7.org/fhir/us/pq-cmc-fda/ValueSet/pqcmc-product-part-ingredient-physical-location | Ingredient Location Terminology |
http://hl7.org/fhir/us/pq-cmc-fda/ValueSet/pqcmc-product-part-type | Product Part Type Terminology |
http://hl7.org/fhir/us/pq-cmc-fda/ValueSet/pqcmc-quality-benchmark-terminology | Quality Benchmark Terminology |
http://hl7.org/fhir/us/pq-cmc-fda/ValueSet/pqcmc-release-mechanism | Release Mechanism Terminology |
http://hl7.org/fhir/us/pq-cmc-fda/ValueSet/pqcmc-release-profile | Release Profile Terminology |
http://hl7.org/fhir/us/pq-cmc-fda/ValueSet/pqcmc-representation-types | Representation Types |
http://hl7.org/fhir/us/pq-cmc-fda/ValueSet/pqcmc-source-type-terminology | Source Type Terminology |
http://hl7.org/fhir/us/pq-cmc-fda/ValueSet/pqcmc-specification-status-terminology | Specification Status Terminology |
http://hl7.org/fhir/us/pq-cmc-fda/ValueSet/pqcmc-specification-type-terminology | Specification Type Terminology |
http://hl7.org/fhir/us/pq-cmc-fda/ValueSet/pqcmc-strength-type-terminology | Strength Type Terminology |
http://hl7.org/fhir/us/pq-cmc-fda/ValueSet/pqcmc-substance-name-type | Substance Name Type |
http://hl7.org/fhir/us/pq-cmc-fda/ValueSet/pqcmc-test-category-terminology | Test Category Terminology |
http://hl7.org/fhir/us/pq-cmc-fda/ValueSet/pqcmc-test-method-origin-terminology | Test Method Origin Terminology |
http://hl7.org/fhir/us/pq-cmc-fda/ValueSet/pqcmc-test-usage-terminology | Test Usage Terminology |
http://hl7.org/fhir/us/pq-cmc-fda/ValueSet/spl-drug-route-of-administration-terminology | Drug Route Of Administration Terminology |
http://hl7.org/fhir/us/pq-cmc-fda/ValueSet/spl-pharmaceutical-dosage-form-terminology | Pharmaceutical Dosage Form Terminology |
http://hl7.org/fhir/us/pq-cmc-fda/ValueSet/substance-classification | Substance Classification |
http://hl7.org/fhir/uv/genomics-reporting/ValueSet/molecular-biomarker-code-vs | Molecular Biomarker Codes |
https://www.nfdi4health.de/fhir/metadataschema/ValueSet/nfdi4health-vs-mds-cd-datacollected-nci | NFDI4Health Data Collected [NCI] |
https://www.nfdi4health.de/fhir/metadataschema/ValueSet/nfdi4health-vs-mds-cd-information-sources-nci-local | NFDI4Health Data Collected [NCI] |
https://www.nfdi4health.de/fhir/metadataschema/ValueSet/nfdi4health-vs-mds-id-type-nci-local | NFDI4Health VS MDS ID Type [NCI, local] |
https://www.nfdi4health.de/fhir/metadataschema/ValueSet/nfdi4health-vs-mds-identifier-type-related-artifact-nci-local | NFDI4Health VS MDS Identifier Type Related Artifact [NCI, local] |
https://www.nfdi4health.de/fhir/metadataschema/ValueSet/nfdi4health-vs-mds-mortality-data-nci | NFDI4Health VS MDS Mortality Data [NCI] |
https://www.nfdi4health.de/fhir/metadataschema/ValueSet/nfdi4health-vs-mds-ne-instrument-nci-local | NFDI4Health NE Instrument [NCI, Local] |
https://www.nfdi4health.de/fhir/metadataschema/ValueSet/nfdi4health-vs-mds-ne-mode-nci-msh-local | NFDI4Health NE Mode [NCI, MeSH, Local] |
https://www.nfdi4health.de/fhir/metadataschema/ValueSet/nfdi4health-vs-mds-organisational-roles-nci-local | NFDI4Health VS MDS Organisational Roles [NCI, local] |
https://www.nfdi4health.de/fhir/metadataschema/ValueSet/nfdi4health-vs-mds-personal-roles-nci-local | NFDI4Health VS MDS Personal Roles [NCI, local] |
https://www.nfdi4health.de/fhir/metadataschema/ValueSet/nfdi4health-vs-mds-population-coverage-nci | NFDI4Health VS MDS Population Coverage [NCI] |
https://www.nfdi4health.de/fhir/metadataschema/ValueSet/nfdi4health-vs-mds-resource-type-general-nci-msh-local | NFDI4Health VS MDS Resource Type General [NCI, MSH, local] |
https://www.nfdi4health.de/fhir/metadataschema/ValueSet/nfdi4health-vs-mds-resource-type-nci-local | NFDI4Health VS MDS Resource Type [NCI, Local] |
https://www.nfdi4health.de/fhir/metadataschema/ValueSet/nfdi4health-vs-mds-study-allocation-nci | NFDI4Health VS MDS Study Allocation [NCI] |
https://www.nfdi4health.de/fhir/metadataschema/ValueSet/nfdi4health-vs-mds-study-arm-group-type-nci | NFDI4Health VS MDS Study Arm Group Type [NCI] |
https://www.nfdi4health.de/fhir/metadataschema/ValueSet/nfdi4health-vs-mds-study-assessments-sct-nci | NFDI4Health VS MDS Study Assessments [SCT, NCI] |
https://www.nfdi4health.de/fhir/metadataschema/ValueSet/nfdi4health-vs-mds-study-biospecimen-retention-nci | NFDI4Health VS MDS Study Biospecimen Retention [NCI] |
https://www.nfdi4health.de/fhir/metadataschema/ValueSet/nfdi4health-vs-mds-study-conditions-classification-nci-local | NFDI4Health VS MDS Study Conditions Classification [NCI, Local] |
https://www.nfdi4health.de/fhir/metadataschema/ValueSet/nfdi4health-vs-mds-study-data-sharing-plan-ds-sct-nci | NFDI4Health VS MDS Study Data Sharing Plan Datashield [SCT, NCI] |
https://www.nfdi4health.de/fhir/metadataschema/ValueSet/nfdi4health-vs-mds-study-data-sharing-plan-sup-inf-nci-local | NFDI4Health VS MDS Study Data Sharing Plan Supporting Information [NCI, local] |
https://www.nfdi4health.de/fhir/metadataschema/ValueSet/nfdi4health-vs-mds-study-data-sources-general-nci-local | NFDI4Health VS MDS Study Data Sources General [NCI, local] |
https://www.nfdi4health.de/fhir/metadataschema/ValueSet/nfdi4health-vs-mds-study-data-sources-imaging-nci | NFDI4Health VS MDS Study Data Sources Imaging [NCI] |
https://www.nfdi4health.de/fhir/metadataschema/ValueSet/nfdi4health-vs-mds-study-data-sources-omics-nci | NFDI4Health VS MDS Study Data Sources Omics [NCI] |
https://www.nfdi4health.de/fhir/metadataschema/ValueSet/nfdi4health-vs-mds-study-ds-biosamples-sct-nci | NFDI4Health VS MDS Study Data Sources Biosamples [SCT, NCI] |
https://www.nfdi4health.de/fhir/metadataschema/ValueSet/nfdi4health-vs-mds-study-ethics-committee-approval-nci-local | NFDI4Health VS MDS Study Ethics Commitee Approval [NCI, local] |
https://www.nfdi4health.de/fhir/metadataschema/ValueSet/nfdi4health-vs-mds-study-exposure-type-nci | NFDI4Health VS MDS Study Exposure Type [NCI] |
https://www.nfdi4health.de/fhir/metadataschema/ValueSet/nfdi4health-vs-mds-study-group-characteristics-nci | NFDI4Health VS MDS Study Group Characteristics [NCI] |
https://www.nfdi4health.de/fhir/metadataschema/ValueSet/nfdi4health-vs-mds-study-intervention-type-nci | NFDI4Health VS MDS Study Intervention Type [NCI] |
https://www.nfdi4health.de/fhir/metadataschema/ValueSet/nfdi4health-vs-mds-study-masking-roles-nci-local | NFDI4Health VS MDS Study Masking Roles [NCI, local] |
https://www.nfdi4health.de/fhir/metadataschema/ValueSet/nfdi4health-vs-mds-study-outcome-type-nci | NFDI4Health VS MDS Study Outcome Type [NCI] |
https://www.nfdi4health.de/fhir/metadataschema/ValueSet/nfdi4health-vs-mds-study-overall-status-nci-local | NFDI4Health VS MDS Study Overall Status [NCI, Local] |
https://www.nfdi4health.de/fhir/metadataschema/ValueSet/nfdi4health-vs-mds-study-phase-nci | NFDI4Health VS MDS Study Phase [NCI] |
https://www.nfdi4health.de/fhir/metadataschema/ValueSet/nfdi4health-vs-mds-study-primary-design-nci | NFDI4Health VS MDS Study Primary Design [NCI] |
https://www.nfdi4health.de/fhir/metadataschema/ValueSet/nfdi4health-vs-mds-study-primary-purpose-hl7-nci | NFDI4Health VS MDS Study Primary Purpose [HL7, NCI] |
https://www.nfdi4health.de/fhir/metadataschema/ValueSet/nfdi4health-vs-mds-study-recruitment-register-nci-sct-local | NFDI4Health VS MDS Study Recruitment Register [NCI, SCT, Local] |
https://www.nfdi4health.de/fhir/metadataschema/ValueSet/nfdi4health-vs-mds-study-sampling-method-nci-local | NFDI4Health VS MDS Study Sampling Method [NCI, local] |
https://www.nfdi4health.de/fhir/metadataschema/ValueSet/nfdi4health-vs-mds-study-sampling-method-non-prob-nci-local | NFDI4Health VS MDS Study Sampling Method Non Probability [NCI, local] |
https://www.nfdi4health.de/fhir/metadataschema/ValueSet/nfdi4health-vs-mds-study-sampling-prob-method-nci-local | NFDI4Health VS MDS Study Sampling Probability Method [NCI, Local] |
https://www.nfdi4health.de/fhir/metadataschema/ValueSet/nfdi4health-vs-mds-study-time-perspectives-nci | NFDI4Health VS MDS Study Time Perspectives [NCI] |
https://www.nfdi4health.de/fhir/metadataschema/ValueSet/nfdi4health-vs-mds-study-type-interventional-nci | NFDI4Health VS MDS Study Type Interventional [NCI] |
https://www.nfdi4health.de/fhir/metadataschema/ValueSet/nfdi4health-vs-mds-study-type-non-interventional-nci-msh-local | NFDI4Health VS MDS Study Type Non Interventional [NCI, MSH, local] |
https://www.nfdi4health.de/fhir/metadataschema/ValueSet/nfdi4health-vs-mds-yes-no-undecided-snomedct-nci | NFDI4Health VS MDS Yes, No, Undecided [SNOMED CT, NCI] |
XIG built as of ??metadata-date??. Found ??metadata-resources?? resources in ??metadata-packages?? packages.